Dieses Ergebnis aus Springer Nature Journals kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

The real-life efficacy and safety of osimertinib in pretreated advanced non-small cell lung cancer patients with T790M mutation: a Turkish Oncology Group Study

Title:	The real-life efficacy and safety of osimertinib in pretreated advanced non-small cell lung cancer patients with T790M mutation: a Turkish Oncology Group Study
Authors:	Hizal, Mutlu^{Aff1, IDs00432021037487_cor1}; Bilgin, Burak^Aff2; Paksoy, Nail^Aff3; Açıkgöz, Özgür^Aff4; Sezer, Ahmet^Aff5; Gürbüz, Mustafa^Aff6; Ak, Naziye^Aff7; Yücel, Şebnem^Aff2; Ayhan, Murat^Aff8; Erol, Cihan^Aff9; Demirkıran, Aykut^Aff10; Mandel, Nil Molinas^Aff11; Shbair, Abdallah^Aff12; Gökmen, İvo^Aff13; Başoğlu, Tuğba^Aff14; Paydaş, Semra^Aff15; Demiray, Atike Gökçen^Aff16; İriağaç, Yakup^Aff17; Şakalar, Teoman^Aff18; Zeynelgil, Esra^Aff19; Tatlı, Ali Murat^Aff20; Bahçeci, Aykut^Aff21; Güven, Deniz Can^Aff22; Caner, Burcu^Aff23; Can, Alper^Aff24; Gülmez, Ahmet^Aff25; Karakaş, Yusuf^Aff26; Yalçın, Bülent^Aff9; Demirkazık, Ahmet^Aff6; Bilici, Ahmet^Aff4; Aydıner, Adnan^Aff3; Yumuk, Perran Fulden^Aff14; Şendur, Mehmet Ali Nahit^Aff9
Source:	Journal of Cancer Research and Clinical Oncology. 148(6):1501-1508
Database:	Springer Nature Journals